CIK 0001048477
- Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680397820
- Phone
- +1 415-506-6700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,163,748
- in 1 filing
Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-16 | Mueller Brian EVP, Chief Financial Officer | Shares withheld for taxes | −3,973 | $93.41 | $371K | 55,585 |
| 2023-03-16 | FUCHS HENRY J President, Worldwide R&D | Shares withheld for taxes | −36,000 | $93.41 | $3.4M | 188,187 |
| 2023-03-16 | Davis George Eric EVP, Chief Legal Officer | Shares withheld for taxes | −19,957 | $93.41 | $1.9M | 80,367 |
| 2023-03-16 | BIENAIME JEAN JACQUES Chief Executive Officer | Shares withheld for taxes | −88,623 | $93.41 | $8.3M | 425,896 |
| 2023-03-16 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Shares withheld for taxes | −20,510 | $93.41 | $1.9M | 65,486 |
| 2023-03-15 | Guyer Charles Greg EVP, Chief Technical Officer | Grant or award | +8,900 | 51,320 | ||
| 2023-03-15 | Guyer Charles Greg EVP, Chief Technical Officer | Shares withheld for taxes | −1,856 | $87.74 | $163K | 49,464 |
| 2023-03-15 | Guyer Charles Greg EVP, Chief Technical Officer | Grant or award · Stock Option (Right to buy Common Stock) | +20,320 | 20,320 | ||
| 2023-03-15 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +9,630 | 62,266 | ||
| 2023-03-15 | Mueller Brian EVP, Chief Financial Officer | Shares withheld for taxes | −2,708 | $87.74 | $238K | 59,558 |
| 2023-03-15 | Mueller Brian EVP, Chief Financial Officer | Grant or award · Stock Option (Right to buy Common Stock) | +21,970 | 21,970 | ||
| 2023-03-15 | FUCHS HENRY J President, Worldwide R&D | Grant or award | +16,840 | 228,986 | ||
| 2023-03-15 | FUCHS HENRY J President, Worldwide R&D | Shares withheld for taxes | −4,799 | $87.74 | $421K | 224,187 |
| 2023-03-15 | FUCHS HENRY J President, Worldwide R&D | Grant or award · Stock Option (Right to buy Common Stock) | +38,450 | 38,450 | ||
| 2023-03-15 | Davis George Eric EVP, Chief Legal Officer | Grant or award | +8,900 | 103,349 | ||
| 2023-03-15 | Davis George Eric EVP, Chief Legal Officer | Shares withheld for taxes | −3,025 | $87.74 | $265K | 100,324 |
| 2023-03-15 | Davis George Eric EVP, Chief Legal Officer | Grant or award · Stock Option (Right to buy Common Stock) | +20,320 | 20,320 | ||
| 2023-03-15 | Burkhart Erin GVP, Chief Accounting Officer | Grant or award | +3,760 | 14,890 | ||
| 2023-03-15 | Burkhart Erin GVP, Chief Accounting Officer | Grant or award · Stock Option (Right to buy Common Stock) | +5,720 | 5,720 | ||
| 2023-03-15 | BIENAIME JEAN JACQUES Chief Executive Officer | Grant or award | +36,100 | 523,956 |
Page 16 of 23 · 450 trades